US children with developmental disabilities were found to be at a greater risk for asthma; nursing homes attributed to 43% of US deaths due to coronavirus disease 2019 (COVID-19); cloth masks recommended when wearing a mask during exercise.
In a study published in JAMA Network Open, researchers found that the prevalence rate of asthma is greater in US children with developmental disabilities when compared with those without disabilities. Additionally, the odds of asthma were significantly higher in children with developmental disabilities, particularly ethnic minority US children. Researchers found that very young children with asthma should be screened for disabilities or delays due to this potential association.
In a piece by CIDRAP, the impact of the coronavirus disease 2019 (COVID-19) on nursing homes and assisted living facilities was highlighted, with an analysis in The Wall Street Journalindicating that the incidence of death has surpassed 50,000. This figure represents 43% of the overall death toll in the United States (N = 116,700), which may be underreported as not all states have reported nursing home cases and potential deaths.
As people nationwide take alternate approaches to exercise without the availability of gyms, an article in The New York Times highlights the importance of wearing suitable masks during these workouts to promote protection against COVID-19 and optimal breathing. According to the article, researchers found that masks do affect exercise as heart rates tend to increase, as well as the likelihood of feeling lightheaded or dizzy. Researchers recommended avoiding paper, cotton, and surgical masks during exercise as they become wet too rapidly, and to instead use cloth masks made from breathable, synthetic materials.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria
April 16th 2025There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who are difficult to treat.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More